Emory University School of Medicine
Dr. Martha Arellano completed her medical training at Emory University’s School of Medicine. She is an Assistant Professor of Hematology and Oncology at the Winship Cancer Institute of Emory University. Dr. Arellano’s primary research focus is in the development of novel therapies for older adults with acute leukemias and myelodysplastic syndromes and immune-based therapies for hematological malignancies. She is currently principal investigator on four therapeutic trials for older patients with acute myeloid leukemia and an investigator-initiated trial utilizing an immunotherapy combination for patients with leukemia who relapsed after allogeneic transplantation. She is currently working with Dr. H. Jean Khoury to develop a tissue repository for hematological malignancies, a project that has already led to several collaborations with scientists within and outside of Emory University. Dr. Arellano has published in a number of leading journals including Journal of Clinical Oncology, Biology of Blood and Marrow Transplantation and Leukemia and Lymphoma. She has served on the Winship Cancer Institute’s Data Safety Monitoring Committee (DSMC) since 2009. She also served on the University’s Community and Diversity Committee to develop strategies for retention and development of students and trainees at Emory University.
Dr. Arellano's areas of research interest include adoptive immunotherapy for hematopoietic malignancies and novel therapies for acute leukemia and myelodysplastic syndromes.
View publications on PubMed
View clinical trials at Winship Cancer Institute